A comparative study of the effects of ranitidine and cimetidine on carbohydrate tolerance, growth hormone secretion and the hypothalamic-pituitary-gonadal axis in man.
The effect of chronic oral administration of cimetidine (1 g per day) and ranitidine (300 mg per day) on plasma levels of prolactin (PRL), testosterone, dihydrotestosterone (DHT), luteinizing hormone (LH), follicle stimulating hormone (FSH), sex hormone binding globulin (SHBG) and human growth hormone was compared in 2 groups of male patients who presented with dyspeptic symptoms. Eight were treated with ranitidine and 9 with cimetidine for 4 weeks. The glucose and insulin response to a 100 g oral glucose load was also assessed. Cimetidine treatment resulted in a significant increase in plasma testosterone levels which was not found in the ranitidine group. No significant change occurred in PRL, LH, FSH, SHBG, DHT and growth hormone. There was no evidence of a significant alteration in carbohydrate metabolism.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002927:Cimetidine / Q000494:pharmacology*; D004415:Dyspepsia / Q000097:blood; D005951:Glucose Tolerance Test; D012739:Gonadal Steroid Hormones / Q000097:blood; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000378:metabolism; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D011897:Random Allocation; D011899:Ranitidine / Q000494:pharmacology*; D013737:Testis / Q000187:drug effects* / Q000378:metabolism
D001786:Blood Glucose; D012739:Gonadal Steroid Hormones; D007328:Insulin; D002927:Cimetidine; D011899:Ranitidine; D013006:Growth Hormone